Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 94


Diminishing impairments in glucose uptake, mitochondrial content, and ADP-stimulated oxygen flux by mesenchymal stem cell therapy in the infarcted heart.

Hughey CC, James FD, Ma L, Bracy DP, Wang Z, Wasserman DH, Rottman JN, Shearer J.

Am J Physiol Cell Physiol. 2014 Jan 1;306(1):C19-27. doi: 10.1152/ajpcell.00156.2013. Epub 2013 Nov 6.


Mesenchymal stem cell transplantation for the infarcted heart: therapeutic potential for insulin resistance beyond the heart.

Hughey CC, Ma L, James FD, Bracy DP, Wang Z, Wasserman DH, Rottman JN, Hittel DS, Shearer J.

Cardiovasc Diabetol. 2013 Sep 4;12:128. doi: 10.1186/1475-2840-12-128.


Mesenchymal stem cell transplantation for the infarcted heart: a role in minimizing abnormalities in cardiac-specific energy metabolism.

Hughey CC, Johnsen VL, Ma L, James FD, Young PP, Wasserman DH, Rottman JN, Hittel DS, Shearer J.

Am J Physiol Endocrinol Metab. 2012 Jan 15;302(2):E163-72. doi: 10.1152/ajpendo.00443.2011. Epub 2011 Oct 4.


Myocardial infarction in rats causes partial impairment in insulin response associated with reduced fatty acid oxidation and mitochondrial gene expression.

Amorim PA, Nguyen TD, Shingu Y, Schwarzer M, Mohr FW, Schrepper A, Doenst T.

J Thorac Cardiovasc Surg. 2010 Nov;140(5):1160-7. doi: 10.1016/j.jtcvs.2010.08.003. Epub 2010 Sep 17.


The transcriptional coactivator PGC-1alpha is essential for maximal and efficient cardiac mitochondrial fatty acid oxidation and lipid homeostasis.

Lehman JJ, Boudina S, Banke NH, Sambandam N, Han X, Young DM, Leone TC, Gross RW, Lewandowski ED, Abel ED, Kelly DP.

Am J Physiol Heart Circ Physiol. 2008 Jul;295(1):H185-96. doi: 10.1152/ajpheart.00081.2008. Epub 2008 May 16.


Functional and bioenergetic modulations in the infarct border zone following autologous mesenchymal stem cell transplantation.

Feygin J, Mansoor A, Eckman P, Swingen C, Zhang J.

Am J Physiol Heart Circ Physiol. 2007 Sep;293(3):H1772-80. Epub 2007 Jun 15.


Intra-myocardial delivery of mesenchymal stem cells ameliorates left ventricular and cardiomyocyte contractile dysfunction following myocardial infarction.

Li Q, Turdi S, Thomas DP, Zhou T, Ren J.

Toxicol Lett. 2010 Jun 2;195(2-3):119-26. doi: 10.1016/j.toxlet.2010.03.009. Epub 2010 Mar 18.


Overexpression of MicroRNA-1 improves the efficacy of mesenchymal stem cell transplantation after myocardial infarction.

Huang F, Li ML, Fang ZF, Hu XQ, Liu QM, Liu ZJ, Tang L, Zhao YS, Zhou SH.

Cardiology. 2013;125(1):18-30. doi: 10.1159/000347081. Epub 2013 Apr 20.


Insulin-like growth factor 1 alleviates high-fat diet-induced myocardial contractile dysfunction: role of insulin signaling and mitochondrial function.

Zhang Y, Yuan M, Bradley KM, Dong F, Anversa P, Ren J.

Hypertension. 2012 Mar;59(3):680-93. doi: 10.1161/HYPERTENSIONAHA.111.181867. Epub 2012 Jan 23. Erratum in: Hypertension. 2014 Apr;63(4):e92.


Early beneficial effects of bone marrow-derived mesenchymal stem cells overexpressing Akt on cardiac metabolism after myocardial infarction.

Gnecchi M, He H, Melo LG, Noiseaux N, Morello F, de Boer RA, Zhang L, Pratt RE, Dzau VJ, Ingwall JS.

Stem Cells. 2009 Apr;27(4):971-9. doi: 10.1002/stem.12.


Mesenchymal stem cell injection induces cardiac nerve sprouting and increased tenascin expression in a Swine model of myocardial infarction.

Pak HN, Qayyum M, Kim DT, Hamabe A, Miyauchi Y, Lill MC, Frantzen M, Takizawa K, Chen LS, Fishbein MC, Sharifi BG, Chen PS, Makkar R.

J Cardiovasc Electrophysiol. 2003 Aug;14(8):841-8.


VEGF/SDF-1 promotes cardiac stem cell mobilization and myocardial repair in the infarcted heart.

Tang JM, Wang JN, Zhang L, Zheng F, Yang JY, Kong X, Guo LY, Chen L, Huang YZ, Wan Y, Chen SY.

Cardiovasc Res. 2011 Aug 1;91(3):402-11. doi: 10.1093/cvr/cvr053. Epub 2011 Feb 22.


Mesenchymal stem cells overexpressing Akt dramatically repair infarcted myocardium and improve cardiac function despite infrequent cellular fusion or differentiation.

Noiseux N, Gnecchi M, Lopez-Ilasaca M, Zhang L, Solomon SD, Deb A, Dzau VJ, Pratt RE.

Mol Ther. 2006 Dec;14(6):840-50. Epub 2006 Sep 11.


[Beneficial effects of liver X receptor agonist on adipose-derived mesenchymal stem cells transplantation in mice with myocardial infarction].

Li CH, Duan HL, Fan WW, Wang YB, Zhang Z, Zhang RQ, Bu QT, Li XJ, Cao F.

Zhonghua Xin Xue Guan Bing Za Zhi. 2012 Sep;40(9):723-8. Chinese.


Mesenchymal stem cell injection ameliorates the inducibility of ventricular arrhythmias after myocardial infarction in rats.

Wang D, Zhang F, Shen W, Chen M, Yang B, Zhang Y, Cao K.

Int J Cardiol. 2011 Nov 3;152(3):314-20. doi: 10.1016/j.ijcard.2010.07.025. Epub 2010 Aug 2.


MSCs transfected with hepatocyte growth factor or vascular endothelial growth factor improve cardiac function in the infarcted porcine heart by increasing angiogenesis and reducing fibrosis.

Lu F, Zhao X, Wu J, Cui Y, Mao Y, Chen K, Yuan Y, Gong D, Xu Z, Huang S.

Int J Cardiol. 2013 Sep 10;167(6):2524-32. doi: 10.1016/j.ijcard.2012.06.052. Epub 2012 Sep 13.


Impaired insulin signaling accelerates cardiac mitochondrial dysfunction after myocardial infarction.

Sena S, Hu P, Zhang D, Wang X, Wayment B, Olsen C, Avelar E, Abel ED, Litwin SE.

J Mol Cell Cardiol. 2009 Jun;46(6):910-8. doi: 10.1016/j.yjmcc.2009.02.014. Epub 2009 Feb 26.


Genetically manipulated progenitor cell sheet with diprotin A improves myocardial function and repair of infarcted hearts.

Zhang D, Huang W, Dai B, Zhao T, Ashraf A, Millard RW, Ashraf M, Wang Y.

Am J Physiol Heart Circ Physiol. 2010 Nov;299(5):H1339-47. doi: 10.1152/ajpheart.00592.2010. Epub 2010 Aug 27.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk